Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical exampleReport as inadecuate




Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example - Download this document for free, or read online. Document in PDF available to download.

BMC Medical Research Methodology

, 13:142

Data analysis, statistics and modelling

Abstract

BackgroundThe High-Dimensional Propensity Score hd-PS algorithm can select and adjust for baseline confounders of treatment-outcome associations in pharmacoepidemiologic studies that use healthcare claims data. How hd-PS performance is affected by aggregating medications or medical diagnoses has not been assessed.

MethodsWe evaluated the effects of aggregating medications or diagnoses on hd-PS performance in an empirical example using resampled cohorts with small sample size, rare outcome incidence, or low exposure prevalence. In a cohort study comparing the risk of upper gastrointestinal complications in celecoxib or traditional NSAIDs diclofenac, ibuprofen initiators with rheumatoid arthritis and osteoarthritis, we 1 aggregated medications and International Classification of Diseases-9 ICD-9 diagnoses into hierarchies of the Anatomical Therapeutic Chemical classification ATC and the Clinical Classification Software CCS, respectively, and 2 sampled the full cohort using techniques validated by simulations to create 9,600 samples to compare 16 aggregation scenarios across 50% and 20% samples with varying outcome incidence and exposure prevalence. We applied hd-PS to estimate relative risks RR using 5 dimensions, predefined confounders, ≤ 500 hd-PS covariates, and propensity score deciles. For each scenario, we calculated: 1 the geometric mean RR; 2 the difference between the scenario mean lnRR and the lnRR from published randomized controlled trials RCT; and 3 the proportional difference in the degree of estimated confounding between that scenario and the base scenario no aggregation.

ResultsCompared with the base scenario, aggregations of medications into ATC level 4 alone or in combination with aggregation of diagnoses into CCS level 1 improved the hd-PS confounding adjustment in most scenarios, reducing residual confounding compared with the RCT findings by up to 19%.

ConclusionsAggregation of codes using hierarchical coding systems may improve the performance of the hd-PS to control for confounders. The balance of advantages and disadvantages of aggregation is likely to vary across research settings.

KeywordsAggregation Anatomical therapeutic chemical classification Clinical classification software Confounding by indication Infrequent exposure Propensity score Small sample Rare outcome Electronic supplementary materialThe online version of this article doi:10.1186-1471-2288-13-142 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Hoa V Le - Charles Poole - M Alan Brookhart - Victor J Schoenbach - Kathleen J Beach - J Bradley Layton - Til Stürmer

Source: https://link.springer.com/







Related documents